Latest Benzamides Stories
- Revenues increase 56 percent to $18.7 million, loss narrows to $15.1 million - SAN DIEGO, May 11, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
SAN DIEGO, May 4, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Updated clinical data presented in an oral session at the 2015 American Association for Cancer Research Annual Meeting CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals,
UPPSALA, Sweden, April 20, 2015 /PRNewswire/ -- Oasmia Pharmaceutical AB ("Oasmia") announced today that its lead cancer product Paclical received market authorization
Data to support ongoing work with Halozyme's investigational new drug PEGPH20 in combination with immuno-oncology agents SAN DIEGO, April 20, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
Recent FDA meeting allows for potential marketing application based on progression free survival in pivotal Phase 3 pancreatic cancer study SAN DIEGO, April 8, 2015 /PRNewswire/ -- Halozyme
Alimta Compound Patent to Provide Exclusivity in Germany Through December 2015 INDIANAPOLIS, March 6, 2015 /PRNewswire/ -- The German Court of Appeal has ruled that Eli Lilly and Company's
BAUDETTE, Minn., March 5, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc.
EWING, N.J., March 2, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).